1992
DOI: 10.1111/j.1423-0410.1992.tb01210.x
|View full text |Cite
|
Sign up to set email alerts
|

Gift or Good?: A Contemporary Examination of the Voluntary and Commercial Aspects of Blood Donation

Abstract: The safety and ethical aspects of blood donation are examined in the light of current legislation and practice. The advantages and disadvantages of voluntary and paid donation are looked at in view of recent data concerning risk factors in various potential donor groups. It is concluded that voluntary, non-remunerated blood donation remains the safest and most ethical means of securing the blood supply.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
25
0
1

Year Published

1993
1993
2015
2015

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 51 publications
(26 citation statements)
references
References 14 publications
(9 reference statements)
0
25
0
1
Order By: Relevance
“…Other problems may develop from untrained health personnel who may not follow known standards of medical practice for prescribing blood or blood products. The lack of altruistic repeat blood donors, who have been shown to be healthier than re-placement donors and more appropriate than paid donors as source of safe blood, is also a contributing factor (6,17,18,33).…”
mentioning
confidence: 99%
“…Other problems may develop from untrained health personnel who may not follow known standards of medical practice for prescribing blood or blood products. The lack of altruistic repeat blood donors, who have been shown to be healthier than re-placement donors and more appropriate than paid donors as source of safe blood, is also a contributing factor (6,17,18,33).…”
mentioning
confidence: 99%
“…Donating blood voluntarily and without pay is a reflection of socio-ethical values (19). A secondary rationale is that volunteer, unpaid blood donors may be less susceptible to blood-transmissible infections than paid donors (20), although such differences are not always evident (21). International organisations advise member states to remain self-sufficient in blood and plasma products with the help of volunteer, unpaid donors (17), also to prevent the commercialisation of human tissue (22).…”
Section: Transfusion In the Year 2014mentioning
confidence: 99%
“…Even among accepted, first-time donors, prevalence rates for anti-HIV, anti-HCV and hepatitis B markers are a fraction of the na tional population rates. Clearly, however, ac tive selection, dependent upon a donor's selfperceived risk, cannot be expected to be completely successful when 40% or more of infections are not accompanied by known risk factors, as appears to be the case for hepatitis C, for example [5], With the exception of therapeutic doses of random donor platelets, there are no small-pool products currently available in the United States. Single-donor products, such as apheresis platelets, do have some safety advantages based upon reduced donor exposure.…”
Section: R Y Doddmentioning
confidence: 99%